Colchicine prophylaxis in pseudogout.

Abstract

Ten patients with recurrent attacks of pseudogout were followed for 1 year before and 1 year after receiving oral colchicine 0.6 mg BID. Thirty-two episodes of acute arthritis were recorded in the year (3.2/patient/year) before the start of the drug and only 10 while taking the drug (1/patient/year) (p less than 0.001). Ninety percent of the patients benefitted from the drug. Our study supports the effectiveness of oral colchicine as a prophylactic agent in recurring pseudogout.

• Authors: A Alvarellos, I Spilberg
• Journal: The Journal of rheumatology (J Rheumatol) Vol. 13 Issue 4 Pg. 804-5 (Aug 1986) ISSN: 0315-162X [Print] Canada
• PMID: 3772928 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• Colchicine

Topics

• Administration, Oral
• Aged
• Aged, 80 and over
• Arthritis (drug therapy, etiology, prevention & control)
• Chondrocalcinosis (complications, drug therapy, prevention & control)
• Colchicine (administration & dosage, therapeutic use)
• Humans
• Male
• Middle Aged
• Recurrence